[Treatment of inoperable phthisics by transparietal intracavitary continuous drip administration of bacteriostatics].
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D002000:Bronchospirometry; D002404:Catheterization; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007612:Kanamycin / Q000008:administration & dosage*; D008297:Male; D008722:Methods; D008875:Middle Aged; D013450:Sulfones / Q000008:administration & dosage*; D013882:Thiosemicarbazones / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D013450:Sulfones; D013882:Thiosemicarbazones; D007612:Kanamycin
Traitement de phtisiques inopérables par goutte à goutte endocavitaire transpariétal de bactériostatiques.